Clinical Trial

Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

Study acronym: COROS
Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational, retrospective/prospective, multicenter study designed to define, overall survival, clinical outcomes and predictive/prognostic factors of a consecutive population of mCRPC patients treated with olaparib in clinical practice.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-17.
Trial Details
NCT Number NCT06783127
Lead Sponsor Santa Chiara Hospital
Conditions Prostate Cancer, Castrate Resistant Prostate Cancer, BRCA Mutation
Enrollment 3,000 participants
Start Date 2023-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-11